All lobbying filings

MGD STRATEGIES LLC

Lobbying for GO2 FOUNDATION FOR LUNG CANCER-FKA LCA- ON BEHALF OF DEADLIEST CANCERS COALITION · lung cancer advocacy

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Aug 20, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Budget/Appropriations

Report language on deadliest cancers in the FY 2025 Labor, Health & Human Services (LHHS) Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2025 LHHS Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2025 Defense Appropriations bill and the FY2025 Full-Year Continuing Appropriations and Extensions Act Report language on deadliest cancers in the FY 2026 Labor, Health & Human Services (LHHS) Appropriations bill Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2026 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2026 Defense Appropriations bill

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.